Cromolyn sodium: Fitting an old friend into current asthma treatment

Journal of Asthma

Volumn 42, Issue 2, 2005, Pages 79-89

  Storms, William ^a   Kaliner, Michael A ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUORINATED HYDROCARBON; PLACEBO; THEOPHYLLINE;

AEROSOL; AIRWAY OBSTRUCTION; ASTHMA; BEHAVIOR DISORDER; CELL ACTIVATION; CELL ISOLATION; CELL LEVEL; CHANNEL GATING; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRY POWDER; HEADACHE; HEALTH CARE PERSONNEL; HOARSENESS; HUMAN; INFLAMMATORY CELL; INHALER; INHIBITION KINETICS; IRRITABILITY; MAST CELL DEGRANULATION; NAUSEA; NEBULIZER; NERVOUSNESS; NONHUMAN; RASH; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; XEROSTOMIA;

EID: 17744382411     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-52017     Document Type: Review

References (107)

1. Berman BA, Fenton MM, Girsh LS, Haddad ZH, Sellars WA, Strem EL, Thompson HC, Wall LE. Cromolyn sodium in the treatment of children with severe, perennial asthma. Pediatrics 1975; 55(5):621-629.
2. Bernstein IL, Johnson CL. Therapy with cromolyn sodium. Ann Intern Med 1978; 89(2):228-233.
3. Howell JBL, Altounyan RE. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967; 2(7515):539-542.
4. Northern General Hospital, Brompton Hospital, and Medical Research Council Collaborative Trial. Sodium cromoglycate in chronic asthma. Br Med J 1976; 1:361-364.
5. Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 1984; 74(4):453-459.
6. Cox JS. Disodium cromoglycate (FPL 670) ("Intal"): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 1967; 216(122):1328-1329.
7. 14C disodium cromglycate in man. J Pharm Pharmacol 1972; 24:525-531.
8. Moss GF, Jones KM, Ritchie JT, Cox JS. Plasma levels and urinary excretion of disodium cromglycate after inhalation by human volunteers. Toxicol Appl Pharmacol 1971; 20:147-156.
9. Diaz P, Galleguillos FR, Gonzalez MC, Pantin CF, Kay AB. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol 1984; 74(1):41-48.
10. Kay AB, Walsh GM, Moqbel R, MacDonald AJ, Nagakura T, Carroll MP, Richerson HB. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 1987; 80(1):1-8.
11. Tsicopoulos A, Lassalle P, Joseph M, Tonnel AB, Thorel T, Dessaint JP, Capron A. Effect of disodium cromoglycate on inflammatory cells bearing the Fc epsilon receptor (Fc epsilon RII). Int J Immunopharmacol 1988; 10(3):227-236.
12. Rand TH, Lopez AF, Gamble JR, Vadas MA. Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody cytotoxicity. Int Arch Allergy Appl Immunol 1988; 87(2):151-158.
13. Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSDG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin Exp Immunol 1991; 84(3):395-399.
14. Loh RK, Jabara HH, Geha RS. Disodium cromoblycate inhibits S mu → S epsilon deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994; 180(2):663-671.
15. Schmutzler W, Bolsmann K, Zwadio-Klarwavassar G. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells. Int Arch Allergy Immunol 1995; 107(1-3):194-196.
16. Alton EW, Norris AA. Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J Allergy Clin Immunol. 1996; 98(5 Pt 2):S105-S106.
17. Hoshino M, Nakamura Y. The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 1997; 10(4):858-865.
18. Jahnová E, Horváthová M, Gazdik F. Expression of adhesion molecules and effect of disodium cromoglycate treatment in asthmatics. Physiol Res 1998; 47(6):439-443.
19. Sheard P, Blair AMJN. Disodium cromoglycate: activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int Arch Allergy Appl Immunol 1970; 38(2):217-224.
20. Flint KC, Leung KB, Hudspith BN, Pearce FL, Brostoff J, Jhonson NM. The function and properties of human lung mast cells. Respiration 1986; 50:31-41.
21. Leung KB, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Lau HY, Liu WL, Pearce FL. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988; 43(10):756-761.
22. Nagy L. The effect of disodium-chromoglycate on human serum neutrophil-chemotactic activity in antigen-induced bronchospasm. Allergy Immunol (Leipz) 1981; 27(1):48-52.
23. Skedinger MC, Augustine NH, Morris EZ, Nielson DW, Zimmerman GA, Hill HR. Effect of disodium cromoglycate on neutrophil movement and intracellular calcium mobilization. J Allergy Clin Immunul 1987; 80(4):573-577.
24. Moscato G, Rampulla C, Dellabianca A, Zanotti E, Candura S. Effect of salbutamol and inhaled sodium cromoglycate on the airway and neturophil chemotactic activity in 'fog' induced bronchoconstriction. J Allergy Clin Immunol 1988; 82(3 Pt 1):382-388.
25. Bruijnzeel PL, Warringa RA, Kok PT. Inhibition of platelet-activating factor- and zymosan-activated serum- induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Br J Pharmacol 1989; 97(4):1251-1257.
26. Kilpatrick LE, Jakabovics E, McCawley LJ, Kane LH, Korchak HM. Cromolyn inhibits assembly of the NADPH oxidase and superoxide anion generation by human neutrophils. J Immunol 1995; 154(7):3429-3436.
27. Lindqvist A, Karjalainen EM, Laitinen LA, Kava T, Altraja A, Pulkkinen M, Halme M, Laitinen A. Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone priopionate, and disodium cromoglycate. J Allergy Clin Immunol 2002; 112(1):23-28.
28. Horvathova, et al. 1998.
29. Lavin N, Rachelefsky GS, Kaplan SA. An action of disodium cromoglycate: inhibition of cyclic 3′,5′-AMP phosphodiesterase. J Allergy Clin Immunol 1976; 57(1):80-88.
30. Ichikawa K, Baba M, Yoshizawa I, Noma T. Study on the effect of disodium cromoglycate (DSCG) on antigen induced IL_2 responsiveness. Arerugi 1989; 38(10):1163-1168.
31. Holen E, Elsayed S. The effect of disodium cromoglycate (DSCG) on in vitro proliferation of CD4+, CD8+, and CD19+ cell populations derived from allergic and healthy donors. Allergy 1995; 50(3):249-256.
32. Bansai SK, Jha A, Jaiswal AS, Chhabra SK. Increased levels of protein kinase C in lymphosytes in asthma: possible mechanisms of regulation. Eur Respir J 1997; 10(2):308-313.
33. Oh JW, Lee HB, Chung YH, Choi Y. The effect of disodium cromoglycate, budesonide, and cyclosporine A on interleukin-4, interleukin-5, and interleukin-13 secretions in Der pI-stimulated T cells from house dust mite-sensitive atopic and nonatopic individuals. Allergy Asthma Proc 2002; 23(2):109-115.
34. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79(5):734-740.
35. Mattoli S, Foresi A, Corbo GM, Velente S, Ciappi G. Effects of two doses of cromolyn on allergen-induced late asthmatic responses and increased responsiveness. J Allergy Clin Immunol 1987; 79(5):741-754.
36. Pelikan Z, Pelikan-Filipek M, Schoemaker MC, Berger MP. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge I. Immediate response (IAR). Ann Allergy 1988; 60(3):211-216.
37. Pelikan Z, Pelikan-Filipek M, Schoemaker MC, Berger MP. Effects of disodium cromoglycate and beclomethasone dipropionate on the asthmatic response to allergen challenge II. Late response (IAR). Ann Allergy 1988; 60(3):217-225.
38. Heaton RW, Henderson AF, Gray BJ, Costello JF. The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subject. Thorax 1983; 38(7):506-511.
39. Juniper EF, Latimer KM, Morris MM, Roberts RS, Hargreave FE. Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium. J Allergy Clin Immunol 1986; 78(3 Pt 1):387-391.
40. Bascom R, Bleecker ER. Bronchoconstriction induced by distilled water. Sensitivity in asthmatics and relationship to exercise-induced bronchospasm. Am Rev Respir Dis 1986; 134(2):248-253.
41. Black JL, Smith CM, Anderson SD. Cromolyn sodium inhibits the increased responsivenenss to methacholine that follows ultrasonically nebulized water challenge in patients with asthma. J Allergy Clin Immunol 1987; 80(1):39-44.
42. delBufalo D, Fasano L, Patalano F, Gunella G. Inhibition of fog-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in intrinsic asthma: a double-blind, placebo-controlled study. Respiration 1989; 55(3):181-184.
43. Tranfa CM, Vatrella A, Parrella R, Bariffi F. Effect of ipratropium bromide and/or sodium cromoglycate pretreatment on water-induced bronchoconstriction in asthma. Eur Respir J 1995; 8(4):600-604.
44. Siffredi M, Mastropasqua B, Pelucchi A, Chiesa M, Marazzini L, Foresi A. Effect of inhaled furosemide and cromolyn on bronchoconstriction induced by ultrasonically nebulized distilled water in asthmatic subjects. Ann Allergy Asthma Immunol 1997; 78(2):238-243.
45. Kivity S, Yarchovsky J, Greif J, Topilsky M. Combined effect of inhaled verapamil and sodium cromoglycate on the airway response to hypertonic saline. Ann Allergy 1990; 64(2 Pt 1):163-165.
46. Anderson SD, du Toit JI, Rodwell LT, Jenkins CR. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5% saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma. Chest 1994; 105(3):673-680.
47. Crimi N, Palermo F, Vancheri C, Oliveri R, Distefano SM, Polosa R, Mistretta A. Effect of sodium cromoglycate and nifedipine on adenosine-induced bronchoconstriction. Respiration 1988; 53(2):74-80.
48. Phillips GD, Scott VL, Richards R, Holgate ST. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 1989; 2(3):210-217.
49. Sheppard D, Nadel JA, Boushey HA. Inhibition of sulfur dioxide-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects. Am Rev Respir Dis 1981; 124(3):257-259.
50. Tan WC, Cripps E, Doublas N, Sudlow MF. Protective effect of drugs on bronchoconstriction induced by sulphur dioxide. Thorax 1982; 37(9):671-675.
51. Dixon CM, Ind PW. Inhaled sodium metabisuphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1990; 30(3):371-376.
52. Fabbri LM, Mapp CE, Hendrick DJ. Effect of cromolyn on carbachol-induced bronchoconstriction. Ann Allergy 1983; 50(3):195-198.
53. Barbato A, Pisetta F, Mesirca P, Ragusa A, Zacchello F. Sodium cromoglycate and carbachol-induced bronchoprovocation in asthmatic children. Pediatr Pulmonol 1987; 3(3):161-165.
54. Dixon CM, Barnes PJ. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1989; 27(6):831-836.
55. Crimi N, Palermo F, Oliveri R, Vancheri C, Palermo B, Polosa R, Mistretta A. Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate. Respiration 1988; 54:95-99.
56. Miszkiel KA, Beasley R, Holgate ST. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. Br J Clin Pharmacol 1988; 26(3):295-301.
57. Michel O, Ginanni R, Sergysels R. Protective effect of sodium cromoglycate on lipopolysachharide-induced bronchial obstruction in asthmatics. Int Arch Allergy Immunol 1995; 108(3):298-302.
58. Altounyan RE. Inhibition of experimental asthma by a new compound-disodium cromoglycate "Intal." Acta Allergol 1967; 24:487-488.
59. Cox JSG. Disodium cromoglycate: mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest 1971; 65(4):189-204.
60. Orr TSC, Gwilliam J, Cox JS. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reaction. Immunology 1971; 21(3):405-417.
61. Hoshino M, Nakamura Y, Sim JJ, Tomioka H. A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma. Respir Med 1998; 92(7):942-950.
62. Heiman AS, Newton L. Effect of hydrocortisone and disodium cromoglycate on mast cell-mediator release induced by substance P. Pharmacology 1995; 50(4):218-228.
63. Yamawaki I, Tamaoki J, Takeda Y, Nagai A. Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism. Res Commun Molec Pathol Pharmacol 1997; 98(3):265-272.
64. Anderson SD, Rodwell LT, Daviskas E, Spring JF, du Toit J. The protective effect of nedocromil sodium and other drugs on airway narrowing provoked by hyperosmolar stimuli: a role for the airway epithelium? J Allergy Clin Immunol 1996; 98(5 Pt 2):S124-S134.
65. Bernstein IL, Siegel SC, Brandon ML, Brown EB, Evans RR, Feinberg AR, Friedlaender S, Krunholz RA, Hadley RA, Handelman NT, Thurston D, Yamate M. A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 1972; 50(4):235-245.
66. Lal S, Malhotra SM, Gribben MD. Comparison of sodium cromoglycate pressurized aerosol and powder in the treatment of asthma. Clin Allergy 1982; 12(2):197-201.
67. Blumenthal MN, Selcow J, Spector S, Zeiger RS, Mellon M. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma. J Allergy Clin Immunol 1988; 81(4):681-687.
68. Petty TL, Rollins DR, Christopher K, Good JT, Oakley R. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 1989; 139(3):694-701.
69. Glass J, Archer LN, Adams W, Simpson H. Nebulised cromoglycate, theophylline, and placebo in preschool asthmatic children. Arch Dis Child 1981; 56(8):648-651.
70. Prenner BM. Safety, efficacy and bronchodilator-sparing effects of nebulized cromolyn sodium solution in the treatment of asthma in children. Ann Allergy 1982; 49(4):186-190.
71. Newth CJ, Newth CV, Turner JA. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double-blind study. Aust N Z J Med 1982; 12(3):232-238.
72. Stoloff SW. The changing role of theophylline in pediatric asthma. Am Family Physician 1994; 49(4):839-844.
73. Ross RN, Morris M, Sakowitz SR, Berman BA. Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study. Clin Ther 1988; 10(2):188-203.
74. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Plattt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277(11):887-891.
75. Storms W. Double-blind, placebo-controlled study of single doses of chlorofluorocarbon (CFC) and CFC-free cromolyn sodium for exercise-induced bronchoconstriction. Curr Ther Res 1999; 60(12):629-637.
76. National Asthma Education and Prevention Program Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NHLBI, NIH Publication No. 97-4051, 1997.
77. Bousquet J, van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(5 Pt 2):S147-S334.
78. Boner AL, Niero E, Grigolini C, Valletta EA, Biancotto R, Gaburro D. Inhibition of exercise-induced asthma by three forms of sodium cromoglycate. Eur J Respir Dis 1985; 66(1):21-24.
79. Tullett WM, Tan KM, Wall RT, Patel KR. Dose-response effect of sodium cromoglycate pressurized aerosol in exercise induced asthma. 1985; 40(1):41-44.
80. Konig P. The use of cromolyn in the management of hyperreactive airways and exercise. J Allergy Clin Immunol 1984; 73(5 Pt 2):686-689.
81. Bundgaard A, Bach-Mortensen N, Schmidt A. The effect of sodium cromoglycate delivered by Spinhaler and by pressurized aerosol on exercise-induced asthma in children. Clin Allergy 1982; 12(6):601-605.
82. Johnson CE, Belfield PW, Davis S, Cooke NJ, Spencer A, Davies JA. Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol. Thorax 1986; 41(4):290-294.
83. Moqbel R, Durham SR, Shaw RJ, Walsh GM, MacDonald AJ, Mackay JA, Carroll MP, Kay AB. Enchancement of leukocyte cytotoxicity after exercise-induced asthma. Am Rev Respir Dis 1986; 133(4):609-613.
84. Melo RE, Solé D, Naspitz CK. Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol 1997; 99(2):204-209.
85. Lee TH, Nagakura T, Papageorgiou N, Cromwell O, Ikura Y, Kay AB. Mediators in exercise-induced asthma. J Allergy Clin Immunol 1984; 73(5 Pt 2):634-639.
86. Woolley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulfate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 1990; 97(1):39-45.
87. Bundgaard A, Buch D, Schmidt A, Bach-Mortensen N. Pretreatment of exercise-induced asthma in children using disodium cromoglycate and fenoterol inhalation powder. Eur J Respir Dis 1983; 130:36-41.
88. Blumenthal MN, Casale TB, Fink JN, Uryniak T, Casty FE. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial. J Allergy Clin Immunol 1998; 101(1):7-13.
89. Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, Hasegawa H, Yoshida S. Cromolyn sodium suppresses eosinophil inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma Immunol 2001; 87(2):146-150.
90. Cockcroft DW. Pharmacologic therapy for asthma: overview and historical perspective. J Clin Pharmacol 1999; 39(3):216-222.
91. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI, NIH Publication No. 02-3659, 2002.
92. Juniper EF, Latimer KM, Morris MM, Roberts RS, Hargreave FE. Airway responses to hyperventilation of cold dry air: duration of protection by cromolyn sodium. J Allergy Clin Immunol 1986; 78(3 Pt 1):387-391.
93. Patel KR, Kerr JW. The dose-duration effect of sodium cromoglycate in exercise-induced asthma. Clin Allergy 1984; 14(1):87-91.
94. Brooks CD, Nelson A, Metzler C. Attenuation of protection with repeated cromolyn sodium before exercise challenge in subjects with asthma. J Clin Pharmacol 1986; 26(2):91-96.
95. del Bufalo D, Fasano L, Patalano F, Ruggieri F, Gunella G. Prevention of non-specific bronchial hyperreactivity. Dose-dependent effect of sodium cromoglycate metered dose aerosol. Allergol Immunopathol (Madr) 1988; 16(2):77-80.
96. Furosho K, Nishikawa K, Sasaki S, Akasaka T, Arita M, Edwards A. The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children. Pediatr Allergy Immunol 2002; 13:209-216.
97. van den Toorn LM. Clinical implications of airway inflammation in mild intermittent asthma. Ann Allergy Asthma Immunol 2004; 92(6):589-594.
98. Konig P. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J Allergy Clin Immunol 2000; 105(2 Pt 2):S575-S585.
99. Harris TAJ, Fuller RW. High dose fluticasone propionate (FP) and its effect on serum cortisol (sCORT) in patients with asthma. Eur Repir J 1996; 9:163S-164S.
100. Graham LM. Balancing safety and efficacy in the treatment of pediatric asthma. J Allergy Clin Immunol 2002; 109(6 Pt 2):S560-S566.
101. Expert Panel Report. Guidelines for the diagnosis and management of asthma - update on selected topics 2002. J Allergy Clin Immunol 2002; 110(5 Pt 2):S141-S219.
102. Mitchell I, Paterson IC, Cameron SJ, Grant IWB. Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination. Br Med J 1976; 2:457-458.
103. Farschou P, Bing J, Edman G, Engel AM. Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double dummy randomized, parallel-group study. Allergy 1994; 49(8):659-664.
104. Petersen W, Karup-Pedersen F, Friis B, Howitz P, Nielsen F, Strömquist LH. Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma. Allergy 1996; 51(12):870-875.
105. Shapiro GG, Sharpe M, DeRouen TA, Pierson WE, Furukawa CT, Virant FS, Bierman CW. Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991; 88(5):742-748.
106. Krawiec ME, Wenzel SE. Inhaled nonsteroidal anti-inflammatory medications in the treatment of asthma. Respir Care Clin N Am 1999; 5(4):555-574.
107. Rebuck AS. Asthma: non-responsiveness to conventional therapy. Eur J Respir Dis 1986; 147:105-109.